Kiora Pharmaceuticals (FRA:7EY) 3-Year EBITDA Growth Rate : 64.70% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kiora Pharmaceuticals 3-Year EBITDA Growth Rate?

Kiora Pharmaceuticals's EBITDA per Share for the three months ended in Mar. 2024 was €3.12.

During the past 3 years, the average EBITDA Per Share Growth Rate was 64.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 51.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 34.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kiora Pharmaceuticals was 64.70% per year. The lowest was -63.50% per year. And the median was 38.10% per year.

Competitive Comparison of Kiora Pharmaceuticals's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Kiora Pharmaceuticals's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kiora Pharmaceuticals's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiora Pharmaceuticals's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kiora Pharmaceuticals's 3-Year EBITDA Growth Rate falls into.

Kiora Pharmaceuticals 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Kiora Pharmaceuticals (FRA:7EY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Kiora Pharmaceuticals 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kiora Pharmaceuticals's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiora Pharmaceuticals (FRA:7EY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiora Pharmaceuticals Inc (FRA:7EY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

KPRX:USA

Address

332 Encinitas Blvd, Suite 102, Encinitas, CA, USA, 92024

Website

https://www.kiorapharma.com

Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. It operates in one reportable segment operations and manages.

Kiora Pharmaceuticals (FRA:7EY) Headlines

No Headlines